MAPT and tauopathy: On the other hand, they also highlight a novel molecular mechanism where tau-driven m6A modifications might promote circRNA formation and contribute to neurotoxicity, thus opening a possible therapeutic strategy for tauopathies (Atrian et al., 2024).